IL2 and B-cell chronic lymphocytic leukemia: To discern a mechanism for the improved CAR T-cell responses against CLL cells with IL2 addition, we immunophenotyped primary CLL cells incubated for 5 days with high-dose (100 U/mL) IL2 (Supplementary Fig. S2A).